Glucovance Generics Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
Ivax launched its generic version of Bristol-Myers Squibb's Glucovance (glyburide/metformin) May 4, triggering 180 days of marketing exclusivity
You may also be interested in...
Ivax Glucovance ANDA Approved; Inventory Build-Up Underway
The company holds first-to-file rights for generic of Bristol's antidiabetic, which lost marketing exclusivity Jan. 31.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.